Navigation Links
Lyphochek Elevated Immunosuppressant Control

ProductsLyphochek Elevated Immunosuppressant Control
Company Bio-Rad Laboratories
Item Lyphochek Elevated Immunosuppressant Control
Features 
  • Stable for up to three-years when stored refrigerated (28C)
  • Once opened and reconstituted, these controls can be stored either refrigerated (28C) for 14 days or frozen (-10 to -20C) for 30 days
Description Lyphochek Elevated Immunosuppressant Control is a bilevel Cyclosporine control product, prepared from human whole blood. This unique product is ideal for use with assay methods that monitor very high Cyclosporine levels, such as C2 monitoring, which measures Cyclosporine levels in transplant patients at two hours post-dose.

Lyphochek Elevated Immunosuppressant Control can also be used with the Lyphochek Whole Blood Control, providing laboratories with a choice of five levels of Cyclosporine, to monitor the performance of popular testing methods across the entire assay range.

Info Bio-Rad Laboratories
Customer Service: 1-800-2-BIORAD
Web site: http://www.bio-rad.com

Related medicine products :

1. Lyphochek Immunology Plus Control
2. Lyphochek Immunoassay Plus Control
3. Lyphochek Hypertension Markers Control
4. Lyphochek Maternal Serum Control
5. Lyphochek Fertility Control
6. Lyphochek Tumor Marker Control
7. Lyphochek Anemia Control
8. Lyphochek Urine Bone Markers Control
9. Lyphochek Whole Blood Control
10. Lyphochek Quantitative Urine Control
11. Lyphochek Urine Metals Control
The fabric is antistatic and non-linting and is both oil and water repellent.These superior blankets are an environmental friendly alternative to disposable blankets....
The upper body blanket covers the upper torso, arms, neck, and head of the patient....
This product is for the upper body and uses a Convective Warming System which is both soft and comfortable. Constructed of 2-ply material consisting of polyethylene film inner layer and non-woven out...
The Electri-Cool® II is the premier choice when it comes to localized cold therapy systems. system offers the widest variety of application-specific pads and wraps, for your convenience....
Medicine Products:
(Date:3/29/2017)... MD (PRWEB) , ... March 29, 2017 , ... ... is proud to announce the finalization of the company’s executive management team with prominent ... and leading operations is Curio Wellness’ Chief Operating Officer, Ted Dumbauld , who ...
(Date:3/29/2017)... Linda, Ca (PRWEB) , ... March 29, 2017 , ... ... of a growing number of cancers and is touted to be the next revolution ... treatment, thus far, has been in the form of immune checkpoint inhibitors such as ...
(Date:3/29/2017)... ... 29, 2017 , ... The Wharton School of the University of Pennsylvania is ... made a $10 million gift to establish the Ken Moelis and Julie Taffet ... to a Wharton MBA for highly-qualified Penn undergraduates whose academic and career interests expand ...
(Date:3/28/2017)... CA (PRWEB) , ... March 28, 2017 , ... Tuesday, ... asking the American public to take the Diabetes Risk Test to find out if ... the Los Angeles World Airports will light up the evening sky by programming the ...
(Date:3/28/2017)... ... March 28, 2017 , ... Resoundant, ... be invited to the Siemens Healthineers annual customer education symposium, a world-class learning ... take place from March 27 - 31, 2017 at the Atlanta Marriott Marquis ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... Research and Markets has announced the addition of the ... to their offering. ... The ablation device global market is expected to grow at ... Ablation is the minimally invasive therapeutic tissue excision procedure ... tissue removal, to the removal of abnormally conducting cardiac tissue in ...
(Date:3/29/2017)...   Royal Philips (NYSE: PHG, AEX: ... PathAI, a company that develops artificial intelligence technology ... develop solutions that improve the precision and accuracy ... The partnership aims to build deep learning applications ... intelligence to be applied to massive pathology data ...
(Date:3/29/2017)... , March 29, 2017 On March 28, the U.S. ... adult patients with relapsing forms of multiple sclerosis (MS) ... first drug approved by the FDA for PPMS. Ocrevus ... professional.  "Multiple sclerosis can have a ... Dunn , M.D., director of the Division of Neurology ...
Breaking Medicine Technology: